Cefoxitin-based antibiotic therapy for ESBL-producing Enterobacteriaceae prostatitis: A prospective pilot-study
International Journal of Antimicrobial Agents Feb 08, 2018
Demonchy E, et al. - In this study, the efficacy of a cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) prostatitis was reported. Findings suggested that for difficult-to-treat ESBL-E infections as prostatitis, cefoxitin-based antibiotic therapy was suitable.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
